Terray Therapeutics
Latest round
- Series B
Last raised
- Oct 2024
Total raised
- $201M
Investors
- 12
About Terray Therapeutics
Terray Therapeutics, Inc.Founded in 2018, Terray Therapeutics, Inc. specializes in drug discovery solutions.00 mn on October 17, 2024. Eli Berlin is the founder, and Jacob Berlin serves as the CEO.Terray Therapeutics focuses on innovative drug discovery solutions through its proprietary technology platform, which accelerates the development of novel therapeutic compounds. The company offers advanced computational tools and high-throughput screening methods, facilitating the identification of potential drug candidates aimed at oncology and autoimmune disorders.Terray Therapeutics generates revenue through partnerships and collaborations with pharmaceutical companies. Its business model includes B2B transactions where clients utilize the company's technology for drug discovery, typically through contracted agreements and joint research initiatives.00 mn will be utilized to accelerate drug discovery and development utilizing their AI platform. Plans for future growth include the introduction of new products aimed at enhancing drug development processes, with specific timelines for launches yet to be disclosed. Moreover, Terray Therapeutics is actively seeking to expand its presence in international markets, although specific regions and timelines for this expansion have not been publicly outlined.
Who invested in Terray Therapeutics
12 investors across 5 rounds
See all investors in Terray Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Terray Therapeutics
Who invested in Terray Therapeutics?
Terray Therapeutics has 12 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Terray Therapeutics raised?
Terray Therapeutics has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Terray Therapeutics last raise money?
Terray Therapeutics's most recent round on record is a Series B, in Oct 2024.
What does Terray Therapeutics do?
Terray Therapeutics is a biotechnology company.
Where is Terray Therapeutics headquartered?
Terray Therapeutics is headquartered in Monrovia, US.
Which VCs invest in companies like Terray Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Terray Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Terray Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.